{'fraction_non_alphanumeric': 0.018410852713178296, 'fraction_numerical': 0.007751937984496124, 'mean_word_length': 5.49685534591195, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
“INTRAVITREAL DEXAMETHASONE AN EFFECTIVE TREATMENT IN CASES OF RECURRENT MACULAR OEDEMA IN CRVO”

Retinal vein occlusion is second most common retinal vascular disease after diabetic retinopathy. Macular oedema secondary to RVO is the second
most common retinal vascular disease after diabetic retinopathy. Various treatment options have been mentioned in literature i.e., Anti VEGF
injections, retinal laser, corticosteroids, vitrectomy, etc. We here with report a case of CRVO with recurrent macular edema even after 2 monthly
doses of intravitreal ranibizumab injections who responded very well by single intravitreal injection of dexamethasone implant (Ozurdex). Till 3
months post injection of single dexamethasone implant, visual acuity was stable at 6/12 with maintaining of central foveal thickness below 250
microns without requiring of any other further mode of treatment. So we conclude that dexamethasone intravitreal implant is a very good effective
mode of treatment in such cases of CRVO with recurrent macular edema.